Characterization of cardiovascular involvement in pseudoxanthoma elasticum families

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 11, 2013, Pages 2646-2652

  Campens, Laurence ^a   Vanakker, Olivier M ^a   Trachet, Bram ^b   Segers, Patrick ^b   Leroy, Bart P ^a   De Zaeytijd, Julie ^a   Voet, Dirk ^a   De Paepe, Anne ^a   De Backer, Tine ^a   De Backer, Julie ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

atherosclerosis; carotid intima media thickness; pseudoxanthoma elasticum; vascular stiffness; ventricular function

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ABCC6 GENE; ADOLESCENT; ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOTE; HUMAN; HYPERTENSION; IMAGING; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; PULSE WAVE; ULTRASOUND; VASCULAR IMAGING;

ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; PSEUDOXANTHOMA ELASTICUM; VASCULAR STIFFNESS; VENTRICULAR FUNCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTIC DISEASES; ATHEROSCLEROSIS; FEMALE; GENES, RECESSIVE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PERIPHERAL ARTERIAL DISEASE; PHENOTYPE; PREVALENCE; PSEUDOXANTHOMA ELASTICUM; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84887028870     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301901     Document Type: Article

References (41)

1. Uitto J, Li Q, Jiang Q. Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms. J Invest Dermatol. 2010;130:661-670.
2. Gliem M, Zaeytijd JD, Finger RP, Holz FG, Leroy BP, Charbel Issa P. An update on the ocular phenotype in patients with pseudoxanthoma elasti-cum. Front Genet. 2013;4:14.
3. Vanakker OM, Leroy BP, Coucke P, Bercovitch LG, Uitto J, Viljoen D, Terry SF, Van Acker P, Matthys D, Loeys B, De Paepe A. Novel clinico-molecular insights in pseudoxanthoma elasticum provide an effcient molecular screening method and a comprehensive diagnostic fowchart. Hum Mutat. 2008;29:205.
4. Chassaing N, Martin L, Calvas P, Le Bert M, Hovnanian A. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet. 2005;42:881-892.
5. Miwa K, Higashikata T, Mabuchi H. Intravascular ultrasound fndings of coronary wall morphology in a patient with pseudoxanthoma elasticum. Heart. 2004;90:e61.
6. Wegman JJ, Hu X, Tan H, Bergen AA, Trip MD, Kastelein JJ, Smulders YM. Patients with premature coronary artery disease who carry the ABCC6 R1141X mutation have no pseudoxanthoma elasticum phenotype. Int J Cardiol. 2005;100:389-393.
7. van Soest S, Swart J, Tijmes N, Sandkuijl LA, Rommers J, Bergen AA. A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1. Genome Res. 1997;7:830-834.
8. Köblös G, Andrikovics H, Prohászka Z, Tordai A, Váradi A, Arányi T. The R1141X loss-of-function mutation of the ABCC6 gene is a strong genetic risk factor for coronary artery disease. Genet Test Mol Biomarkers. 2010;14:75-78.
9. Kornet L, Bergen AA, Hoeks AP, Cleutjens JP, Oostra RJ, Daemen MJ, van Soest S, Reneman RS. In patients with pseudoxanthoma elasti-cum a thicker and more elastic carotid artery is associated with elastin fragmentation and proteoglycans accumulation. Ultrasound Med Biol. 2004;30:1041-1048
10. van den Berg JS, Hennekam RC, Cruysberg JR, Steijlen PM, Swart J, Tijmes N, Limburg M. Prevalence of symptomatic intracranial aneurysm and ischaemic stroke in pseudoxanthoma elasticum. Cerebrovasc Dis. 2000;10:315-319.
11. Bock A, Schwegler G. Intracerebral haemorrhage as frst manifestation of pseudoxanthoma elasticum. Clin Neurol Neurosurg. 2008;110:262-264.
12. Trip MD, Smulders YM, Wegman JJ, Hu X, Boer JM, ten Brink JB, Zwinderman AH, Kastelein JJ, Feskens EJ, Bergen AA. Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease. Circulation. 2002;106:773-775.
13. Martin L, Maître F, Bonicel P, Daudon P, Verny C, Bonneau D, Le Saux O, Chassaing N. Heterozygosity for a single mutation in the ABCC6 gene may closely mimic PXE: consequences of this phenotype overlap for the defnition of PXE. Arch Dermatol. 2008;144:301-306.
14. Martin L, Chassaing N, Delaite D, Estève E, Maître F, Le Bert M. Histological skin changes in heterozygote carriers of mutations in ABCC6, the gene causing pseudoxanthoma elasticum. J Eur Acad Dermatol Venereol. 2007;21:368-373.
15. Li Q, Jiang Q, Pfendner E, Váradi A, Uitto J. Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms. Exp Dermatol. 2009;18:1-11.
16. Pfendner EG, Vanakker OM, Terry SF, et al. Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J Med Genet. 2007;44:621-628.
17. Uitto J, Pulkkinen L, Ringpfeil F. Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment-genome interface? Trends Mol Med. 2001;7:13-17.
18. Zarbock R, Hendig D, Szliska C, Kleesiek K, Götting C. Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elas-ticum. Clin Chim Acta. 2010;411:1487-1490.
19. Scheffer GL, Hu X, Pijnenborg AC, Wijnholds J, Bergen AA, Scheper RJ. MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest. 2002;82:515-518.
20. Quaglino D, Boraldi F, Barbieri D, Croce A, Tiozzo R, Pasquali Ronchetti I. Abnormal phenotype of in vitro dermal fbroblasts from patients with Pseudoxanthoma elasticum (PXE). Biochim Biophys Acta. 2000;1501:51-62.
21. Ronchetti I, Boraldi F, Annovi G, Cianciulli P, Quaglino D. Fibroblast involvement in soft connective tissue calcifcation. Front Genet. 2013;4:22.
22. Gheduzzi D, Sammarco R, Quaglino D, Bercovitch L, Terry S, Taylor W, Ronchetti I P. Extracutaneous ultrastructural alterations in pseudoxan-thoma elasticum. Ultrastruct Pathol. 2003;27:375-384.
23. Mendelsohn G, Bulkley BH, Hutchins GM. Cardiovascular manifestations of Pseudoxanthoma elasticum. Arch Pathol Lab Med. 1978;102:298-302.
24. Miki K, Yuri T, Takeda N, Takehana K, Iwasaka T, Tsubura A. An autopsy case of pseudoxanthoma elasticum: histochemical characteristics. Med Mol Morphol. 2007;40:172-177.
25. Nolte KB. Sudden cardiac death owing to pseudoxanthoma elasticum: a case report. Hum Pathol. 2000;31:1002-1004.
26. Lefthériotis G, Abraham P, Le Corre Y, Le Saux O, Henrion D, Ducluzeau PH, Prunier F, Martin L. Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum. J Vasc Surg. 2011;54:1390-1394.
27. Goral V, Demir D, Tuzun Y, Keklikci U, Buyukbayram H, Bayan K, Uyar A. Pseudoxantoma elasticum, as a repetitive upper gastrointestinal hemorrhage cause in a pregnant woman. World J Gastroenterol. 2007;13:3897-3899.
28. Nguyen LD, Terbah M, Daudon P, Martin L. Left ventricular systolic and diastolic function by echocardiogram in pseudoxanthoma elasticum. Am J Cardiol. 2006;97:1535-1537.
29. Perk J, De Backer G., Gohlke H, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med. 2012;19:403-488.
30. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) fnal report. Circulation. 2002; 106: 3143-3421.
31. Laube S, Moss C. Pseudoxanthoma elasticum. Arch Dis Child. 2005;90:754-756.
32. Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, Döring A, Broeckel U, Riegger G, Schunkert H. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J. 2003; 24: 320-328.
33. Correa de Sa DD, Hodge DO, Slusser JP, Redfeld MM, Simari RD, Burnett JC, Chen HH. Progression of preclinical diastolic dysfunction to the development of symptoms. Heart. 2010;96:528-532.
34. Greenland P, Alpert JS, Beller GA, et al; American College of Cardiology Foundation/American Heart Asscoiation Tasl Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:2748-2764.
35. Messerli FH, Mancia G, Conti CR, Pepine CJ. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006;27:2902-3; author reply 2903.
36. Lefthériotis G, Omarjee L, Le Saux O, Henrion D, Abraham P, Prunier F, Willoteaux S, Martin L. The vascular phenotype in pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcifcation. Front Genet. 2013;4:4.
37. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001;32:454-460.
38. Boutouyrie P, Germain DP, Tropeano AI, Laloux B, Carenzi F, Zidi M, Jeunemaitre X, Laurent S. Compressibility of the carotid artery in patients with pseudoxanthoma elasticum. Hypertension. 2001;38:1181-1184.
39. Germain DP, Boutouyrie P, Laloux B, Laurent S. Arterial remodeling and stiffness in patients with pseudoxanthoma elasticum. Arterioscler Thromb Vasc Biol. 2003;23:836-841.
40. Criqui MH. Peripheral arterial disease-epidemiological aspects. Vasc Med. 2001;6(3 Suppl):3-7.
41. Tendera M, Aboyans V, Bartelink ML, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-2906.